Western blot data showed that SL4 treatment reduced the protein expression of PCNA in MDA-MB-231 xenografts as compared to the control group, suggesting that SL4 retarded tumor growth by inhibiting cell proliferation (Fig. 7B). Here, PCNA is linked to neoplasm.